[EN] FLUOROALKOXYBENZYLAMINO DERIVATIVES OF NITROGEN CONTAINING HETEROCYCLES
申请人:PFIZER INC.
公开号:WO1993000331A1
公开(公告)日:1993-01-07
(EN) The present invention relates to novel fluoroalkoxybenzylamino derivatives of nitrogen containing heterocyclic compounds, and specifically, to compounds of formula (I) wherein Q, X1, X2 and X3 are as defined below. These novel compounds are useful in the treatment of inflammatory and central nervous system disorders, as well as other disorders.(FR) La présente invention à trait à de nouveaux dérivés fluoroalcoxybenzylamino de composés hétérocycliques contenant de l'azote et, spécialement, à des composés de la formule (I) dans laquelle Q, X1, X2 et X3 ont la notation ci-définie. Ces nouveaux composés sont utiles pour le traitement des affections inflammatoires et des troubles du système nerveux central ainsi que pour d'autres affections.
Fluoroalkyoxybenzylamino derivatives of nitrogen containing heterocycles
申请人:——
公开号:US20030199540A1
公开(公告)日:2003-10-23
The present invention relates to novel fluoroalkoxybenzylamino derivatives of nitrogen containing heterocyclic compounds, and specifically, to compounds of the formula
1
wherein Q, X
1
, X
2
and X
3
are as defined below. These novel compounds are useful in the treatment of inflammatory and central nervous system disorders, as well as other disorders.
Fluoroalkoxybenzylamino derivatives of nitrogen containing heterocycles
申请人:Pfizer Inc.
公开号:US05744480A1
公开(公告)日:1998-04-28
The present invention relates to novel fluoroalkoxybenzylamino derivatives of nitrogen containing heterocyclic compounds, and specifically, to compounds of the formula ##STR1## wherein Q, X.sup.1, X.sup.2 and X.sup.3 are as defined below. These novel compounds are useful in the treatment of inflammatory and central nervous system disorders, as well as other disorders.
Use of fluoroalkoxybenzylamino derivatives of nitrogen containing heterocycles as substance P receptor antagonists
申请人:Pfizer Products Inc.
公开号:EP1172106A2
公开(公告)日:2002-01-16
The present invention relates to methods of treating various CNS and other disorders by adminstering fluoroalkoxybenzylamino derivatives of nitrogen containing heterocyclic compounds, and specifically, by administering compounds of the formula
wherein Q, X1, X2 and X3 are as defined below, and their pharmaceutically acceptable salts.